📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies. (2018)

First Author: Rotolo A

Attributed to: Imperial Confidence in Concept: ICiC5 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/10428194.2017.1403024

PubMed Identifier: 29165008

Publication URI: http://europepmc.org/abstract/MED/29165008

Type: Journal Article/Review

Volume: 59

Parent Publication: Leukemia & lymphoma

Issue: 9

ISSN: 1026-8022